Seelos Therapeutics Inc (SEEL)

[value1008]

I was going to post another boring quick T.A. post here on a friday night (on a break between some good movies with the wife) and i see some 15 posts here.... Is this how APRIcots party on a Friday night?

Shazam, i think you're right about a certain percentage of men using PDE5s will want to experiment with Vitaros, especially if they get the message from their urologist about how its "FASTER-acting and SAFER on the body." There will be a lot of guys who want faster and safer, even if V is a bit more difficult to apply than popping a pill.

As for Vitaros use by athletes for cramping muscles, can't they just pop a potassium pill or apply Tiger Balm or BenGay ointment?

Unless of course, they want to impress the cheerleaders: "My, what erect calf muscles you have!"

Oh, on APRI's T.A.-- it may seem to have been boring overall today with just a 2-penny gain, but this was an important "confirmation day" of a reversal pattern on the chart, IMO.... We had a 2nd straight day wherein sellers/shorters tried to drive pps below the 200dma at 2.30 and also violate (DG likes the word "penetrate") the rising young 20dma and mid-bolly-band (reminds me of the old joke: teenage girl says to teenage boy, "that's not my belly button you're touching with your finger"; and boy replies, "that's not my finger.")

...but the pps rebounded quickly off that 20dma and mid-bolly and stayed almost the entire day above the 200dma. RSI is staying ABOVE the 50-midpoint looking like it wants to go back up (when have we seen that for APRI??!--not for a long time; it stayed below the 50-midpoint almost all of 2H 2013).

Whoever has been manipulating APRI's pps always (it seems) wants to keep the price "grounded" and testing and re-testing support levels. That's frustrating for longs, but now we're seeing obviously much higher support levels than much of the summer-fall.

Any good news forthcoming next week or not long after and we should be way back up.

Btw, i heard from Lourdes early in week that Pascoe et al. won't be presenting at JPMorgan conf., but they'll be there, making a lot of contacts.